ImmuCell (ICCC) News
NASDAQ: ICCCHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
9.80+0.05 (+0.51%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ICCC news summary
We found 1 recent headline mentioning ImmuCell (ICCC): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, ICCC is up 0.51% at $9.80. The most recent story, "Top Research Reports for Alphabet, Mastercard & AbbVie", was published by Nasdaq on Sep 28, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology